These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 19309363)

  • 21. The tumor marker Fascin is induced by the Epstein-Barr virus-encoded oncoprotein LMP1 via NF-κB in lymphocytes and contributes to their invasive migration.
    Mohr CF; Kalmer M; Gross C; Mann MC; Sterz KR; Kieser A; Fleckenstein B; Kress AK
    Cell Commun Signal; 2014 Jul; 12():46. PubMed ID: 25105941
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells.
    Pajic A; Staege MS; Dudziak D; Schuhmacher M; Spitkovsky D; Eissner G; Brielmeier M; Polack A; Bornkamm GW
    Int J Cancer; 2001 Sep; 93(6):810-6. PubMed ID: 11519042
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epstein-Barr virus latent membrane protein 2A (LMP2A) employs the SLP-65 signaling module.
    Engels N; Merchant M; Pappu R; Chan AC; Longnecker R; Wienands J
    J Exp Med; 2001 Aug; 194(3):255-64. PubMed ID: 11489945
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differential signaling pathways are activated in the Epstein-Barr virus-associated malignancies nasopharyngeal carcinoma and Hodgkin lymphoma.
    Morrison JA; Gulley ML; Pathmanathan R; Raab-Traub N
    Cancer Res; 2004 Aug; 64(15):5251-60. PubMed ID: 15289331
    [TBL] [Abstract][Full Text] [Related]  

  • 25. RelB nuclear translocation mediated by C-terminal activator regions of Epstein-Barr virus-encoded latent membrane protein 1 and its effect on antigen-presenting function in B cells.
    Pai S; O'Sullivan BJ; Cooper L; Thomas R; Khanna R
    J Virol; 2002 Feb; 76(4):1914-21. PubMed ID: 11799186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Modulation of B-cell endoplasmic reticulum calcium homeostasis by Epstein-Barr virus latent membrane protein-1.
    Dellis O; Arbabian A; Brouland JP; Kovàcs T; Rowe M; Chomienne C; Joab I; Papp B
    Mol Cancer; 2009 Aug; 8():59. PubMed ID: 19650915
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteins.
    Gires O; Kohlhuber F; Kilger E; Baumann M; Kieser A; Kaiser C; Zeidler R; Scheffer B; Ueffing M; Hammerschmidt W
    EMBO J; 1999 Jun; 18(11):3064-73. PubMed ID: 10357818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor.
    Kilger E; Kieser A; Baumann M; Hammerschmidt W
    EMBO J; 1998 Mar; 17(6):1700-9. PubMed ID: 9501091
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A novel dominant-negative mutant form of Epstein-Barr virus latent membrane protein-1 (LMP1) selectively and differentially impairs LMP1 and TNF signaling pathways.
    Adriaenssens E; Mougel A; Goormachtigh G; Loing E; Fafeur V; Auriault C; Coll J
    Oncogene; 2004 Apr; 23(15):2681-93. PubMed ID: 14767477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LMP1 strain variants: biological and molecular properties.
    Mainou BA; Raab-Traub N
    J Virol; 2006 Jul; 80(13):6458-68. PubMed ID: 16775333
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Src kinase and Syk activation initiate PI3K signaling by a chimeric latent membrane protein 1 in Epstein-Barr virus (EBV)+ B cell lymphomas.
    Hatton O; Lambert SL; Krams SM; Martinez OM
    PLoS One; 2012; 7(8):e42610. PubMed ID: 22880054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tyrosines 60, 64, and 101 of Epstein-Barr virus LMP2A are not essential for blocking B cell signal transduction.
    Swart R; Fruehling S; Longnecker R
    Virology; 1999 Oct; 263(2):485-95. PubMed ID: 10544120
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Latent membrane protein 2A-mediated effects on the phosphatidylinositol 3-Kinase/Akt pathway.
    Swart R; Ruf IK; Sample J; Longnecker R
    J Virol; 2000 Nov; 74(22):10838-45. PubMed ID: 11044134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epstein-Barr virus activates beta-catenin in type III latently infected B lymphocyte lines: association with deubiquitinating enzymes.
    Shackelford J; Maier C; Pagano JS
    Proc Natl Acad Sci U S A; 2003 Dec; 100(26):15572-6. PubMed ID: 14663138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gonadotropin-induced apoptosis in human ovarian surface epithelial cells is associated with cyclooxygenase-2 up-regulation via the beta-catenin/T-cell factor signaling pathway.
    Pon YL; Wong AS
    Mol Endocrinol; 2006 Dec; 20(12):3336-50. PubMed ID: 16945989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The residues between the two transformation effector sites of Epstein-Barr virus latent membrane protein 1 are not critical for B-lymphocyte growth transformation.
    Izumi KM; Cahir McFarland ED; Riley EA; Rizzo D; Chen Y; Kieff E
    J Virol; 1999 Dec; 73(12):9908-16. PubMed ID: 10559303
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epstein-Barr virus latent membrane protein 1 induces synthesis of hypoxia-inducible factor 1 alpha.
    Wakisaka N; Kondo S; Yoshizaki T; Murono S; Furukawa M; Pagano JS
    Mol Cell Biol; 2004 Jun; 24(12):5223-34. PubMed ID: 15169887
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2.
    Eliopoulos AG; Blake SM; Floettmann JE; Rowe M; Young LS
    J Virol; 1999 Feb; 73(2):1023-35. PubMed ID: 9882303
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epstein-Barr virus latent membrane protein-2A induces ITAM/Syk- and Akt-dependent epithelial migration through αv-integrin membrane translocation.
    Fotheringham JA; Coalson NE; Raab-Traub N
    J Virol; 2012 Oct; 86(19):10308-20. PubMed ID: 22837212
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of host kinase activity altered by the LMP2A signalosome-a therapeutic target for Epstein-Barr virus latency and associated disease.
    Cooper L; Longnecker R
    Antiviral Res; 2002 Dec; 56(3):219-31. PubMed ID: 12406506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.